Table 3.
Disease and Treatment Data
| Characteristic | Number (%) (n=39) |
|---|---|
| Breast cancer-related data | |
| Location | |
| left | 23 (59.0) |
| right | 13 (33.3) |
| bilateral | 3 (7.7) |
| Stage at diagnosis | |
| I | 9 (23.1) |
| II | 21 (53.8) |
| III | 8 (20.5) |
| IV | 1 (2.6) |
| Surgery type | |
| Lumpectomy/Segmental | 17 (43.6) |
| Modified radical mastectomy | 16 (41.0) |
| Radical mastectomy | 3 (7.7) |
| Other | 3 (7.7) |
| Chemotherapy type | |
| Cytoxan Adriamycin 5Fu | 3 (7.7) |
| Adriamycin Cytoxan | 10 (25.6) |
| Cytoxin Methatrexate 5fu | 4 (10.3) |
| Other/Missing/None | 22 (56.4) |
| Radiation | |
| None | 11 (28.2) |
| Some | 28 (71.8) |
| Complete treatment received | |
| Surgery alone | 2 (5.1) |
| Surgery and radiation | 1 (2.6) |
| Surgery and chemotherapy | 9 (23.1) |
| Surgery, radiation, and chemotherapy | 27 (69.2) |
| Time since breast cancer diagnosis, Mean ± SD (years) | 8.57±6.74 |
|
| |
| Lymphedema Data | |
| Location | |
| Left arm | 23 (59.0) |
| Right arm | 16 (41.0) |
| Lymphedema dominant arm | 18 (46.2) |
| BMI Group | |
| <30 | 19 (48.7) |
| ≥30 | 20 (51.3) |
| Lymphedema duration, Mean ± SD (years) | 5.75±4.06 |
| Lymphedema onset since breast cancer diagnosis, Mean ± SD (years) | 2.74±5.65 |